SEP Analytical (Shanghai) Co. Ltd. (301228) - Total Liabilities
Based on the latest financial reports, SEP Analytical (Shanghai) Co. Ltd. (301228) has total liabilities worth CN¥408.85 Million CNY (≈ $59.83 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of SEP Analytical (Shanghai) Co. Ltd. to evaluate the company's liquid asset resilience ratio.
SEP Analytical (Shanghai) Co. Ltd. - Total Liabilities Trend (2019–2025)
This chart illustrates how SEP Analytical (Shanghai) Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SEP Analytical (Shanghai) Co. Ltd. (301228) total assets.
SEP Analytical (Shanghai) Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of SEP Analytical (Shanghai) Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
5I5j Holding Group Co Ltd
SHE:000560
|
China | CN¥16.92 Billion |
|
Sumavision Technologies
SHE:300079
|
China | CN¥431.64 Million |
|
Scope Metals Group Ltd
TA:SCOP
|
Israel | ILA1.18 Billion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL48.92 Billion |
|
Huafa Industrial Co Ltd Zhuhai
SHG:600325
|
China | CN¥244.26 Billion |
|
Upbound Group Inc.
NASDAQ:UPBD
|
USA | $2.37 Billion |
|
Dividend 15 Split Corp
TO:DFN
|
Canada | CA$1.68 Billion |
|
Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund
NYSE:PTA
|
USA | $610.54 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down SEP Analytical (Shanghai) Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is SEP Analytical (Shanghai) Co. Ltd.'s balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SEP Analytical (Shanghai) Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SEP Analytical (Shanghai) Co. Ltd. (2019–2025)
The table below shows the annual total liabilities of SEP Analytical (Shanghai) Co. Ltd. from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥432.93 Million ≈ $63.35 Million |
+28.36% |
| 2024-12-31 | CN¥337.29 Million ≈ $49.36 Million |
+4.70% |
| 2023-12-31 | CN¥322.14 Million ≈ $47.14 Million |
+17.50% |
| 2022-12-31 | CN¥274.15 Million ≈ $40.12 Million |
+18.64% |
| 2021-12-31 | CN¥231.08 Million ≈ $33.81 Million |
-1.13% |
| 2020-12-31 | CN¥233.72 Million ≈ $34.20 Million |
+52.06% |
| 2019-12-31 | CN¥153.70 Million ≈ $22.49 Million |
-- |
About SEP Analytical (Shanghai) Co. Ltd.
SEP Analytical (Shanghai) Co., Ltd. engages in the provision of third-party testing services in China. It offers soil, ground water and wastewater, seawater, solid waste, sludge, edible agricultural products, food, cosmetics, textiles, toys and children's products, occupational health, medicine, and other testing services related to human health. The company is also involved in the provision of i… Read more